CFTR dysregulation drives active selection of the gut microbiome is a research paper published in PLoS Pathogens (2020). On theSindex it has a DataRank of 0. It has been cited 80 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cystic Fibrosis Foundation
Grant: HAJJAR16I0
Cystic Fibrosis Foundation
Grant: HAJJAR18G0
Cystic Fibrosis Foundation
Grant: R565-CR07
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: P30 DK089507
NIH Office of the Director
Grant: K01-OD021420
NIDDK NIH HHS
Grant: P30 DK017047
NIH HHS
Grant: K01 OD021420
NHLBI NIH HHS
Grant: K24 HL141669
National Institutes of Health
Grant: 5K24HL141669-07
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease
National Institutes of Health
Grant: 5P30DK089507-02
Translational Research Center for Expedite Novel Therapies in Cystic Fibrosis
National Institutes of Health
Grant: 1K01OD021420-01
Vitamin D mediated protection in inflammatory bowel disease
National Institutes of Health
Grant: 5K24HL141669-04
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease
FWCI
6.15
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences
Additional file 1 of Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences
Additional file 2 of Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences
Additional file 2 of Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences